3 hours CytomX Therapeutics, Inc. (NASDAQ:CTMX) Receives Consensus Recommendation of “Moderate Buy” from BrokeragesMarketBeat
CytomX Therapeutics, Inc. (NASDAQ:CTMX – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six analysts that are currently covering the company, MarketBeat reports. Three analysts have rated the stock with a hold recomm…
X